B-cell CLL/lymphoma 9, Mouse, Clone: 2D4, Abnova™

Mouse monoclonal antibody raised against a partial recombinant BCL9.

Supplier:  Abnova Corporation H00000607M01

Catalog No. 89-014-060

Description

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq

Sequence: DDDSPPARSPNLPSMNNMPGMGINTQNPRISGPNPVVPMPTLSPMGMTQPLSHSNQMPSPNAVGPNIPPHGVPMGPGLMSHNPIMGHGSQEPPMVPQGRM

Specifications

• Antigen: B-cell CLL/lymphoma 9
• Classification: Monoclonal
• Conjugate: Unconjugated
• Formulation: PBS with no preservative; pH 7.4
• Gene Accession No.: NM_004326
• Gene Symbols: BCL9
• Immunogen: BCL9 (NP_004317, 1036 a.a. ∼ 1135 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
• Quantity: 100 μg
• Research Discipline: Signal Transduction
• Gene ID (Entrez): 607
• Content And Storage: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
• Isotype: IgG1 κ

• Applications: ELISA, Immunofluorescence, Western Blot
• Clone: 2D4
• Description: Mouse monoclonal antibody raised against a partial recombinant BCL9.
• Gene: BCL9
• Gene Alias: LGS/MGC131591
• Host Species: Mouse
• Purification Method: Affinity Purified
• Regulatory Status: RUO
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody